Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy

A randomized study in 44 eyes with a long follow-up time

Francesco Bandello, Rosario Brancato, Giuseppe Trabuccbi, Rosangela Lattanzio, Angela Malegori

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A clinical randomized study using argon-green (532 nm) and diode (810 nm) lasers was carried out on 44 eyes (34 patients) affected by proliferative diabetic retinopathy (PDR), with the aim of evaluating the long-term effects of diode panretinal photocoagulation. Of the total 44 eyes, 22 were randomized to argon laser treatment (ALT) and 22 to diode laser treatment (DLT). The mean follow-up time was 25 ± 5 months in the ALT group versus 24 ± 4 montsh in the DLT group. In the ALT group 20 eyes (91 %) showed regression of PDR whereas 2 eyes (9%) deteriorated. In the DLT group regression of neovascularization was observed in 22 eyes (100%). These results show that the long-term efficacy of diode laser PRP in the treatment of PDR is similar to that of argon-green laser PRP.

Original languageEnglish
Pages (from-to)491-494
Number of pages4
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume231
Issue number9
DOIs
Publication statusPublished - Sep 1993

Fingerprint

Light Coagulation
Argon
Diabetic Retinopathy
Lasers
Semiconductor Lasers
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy : A randomized study in 44 eyes with a long follow-up time. / Bandello, Francesco; Brancato, Rosario; Trabuccbi, Giuseppe; Lattanzio, Rosangela; Malegori, Angela.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 231, No. 9, 09.1993, p. 491-494.

Research output: Contribution to journalArticle

@article{1aa5a88a81fb42f1a37d0e5567a89fd5,
title = "Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: A randomized study in 44 eyes with a long follow-up time",
abstract = "A clinical randomized study using argon-green (532 nm) and diode (810 nm) lasers was carried out on 44 eyes (34 patients) affected by proliferative diabetic retinopathy (PDR), with the aim of evaluating the long-term effects of diode panretinal photocoagulation. Of the total 44 eyes, 22 were randomized to argon laser treatment (ALT) and 22 to diode laser treatment (DLT). The mean follow-up time was 25 ± 5 months in the ALT group versus 24 ± 4 montsh in the DLT group. In the ALT group 20 eyes (91 {\%}) showed regression of PDR whereas 2 eyes (9{\%}) deteriorated. In the DLT group regression of neovascularization was observed in 22 eyes (100{\%}). These results show that the long-term efficacy of diode laser PRP in the treatment of PDR is similar to that of argon-green laser PRP.",
author = "Francesco Bandello and Rosario Brancato and Giuseppe Trabuccbi and Rosangela Lattanzio and Angela Malegori",
year = "1993",
month = "9",
doi = "10.1007/BF00921112",
language = "English",
volume = "231",
pages = "491--494",
journal = "Graefe's Archive for Clinical and Experimental Ophthalmology",
issn = "0721-832X",
number = "9",

}

TY - JOUR

T1 - Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy

T2 - A randomized study in 44 eyes with a long follow-up time

AU - Bandello, Francesco

AU - Brancato, Rosario

AU - Trabuccbi, Giuseppe

AU - Lattanzio, Rosangela

AU - Malegori, Angela

PY - 1993/9

Y1 - 1993/9

N2 - A clinical randomized study using argon-green (532 nm) and diode (810 nm) lasers was carried out on 44 eyes (34 patients) affected by proliferative diabetic retinopathy (PDR), with the aim of evaluating the long-term effects of diode panretinal photocoagulation. Of the total 44 eyes, 22 were randomized to argon laser treatment (ALT) and 22 to diode laser treatment (DLT). The mean follow-up time was 25 ± 5 months in the ALT group versus 24 ± 4 montsh in the DLT group. In the ALT group 20 eyes (91 %) showed regression of PDR whereas 2 eyes (9%) deteriorated. In the DLT group regression of neovascularization was observed in 22 eyes (100%). These results show that the long-term efficacy of diode laser PRP in the treatment of PDR is similar to that of argon-green laser PRP.

AB - A clinical randomized study using argon-green (532 nm) and diode (810 nm) lasers was carried out on 44 eyes (34 patients) affected by proliferative diabetic retinopathy (PDR), with the aim of evaluating the long-term effects of diode panretinal photocoagulation. Of the total 44 eyes, 22 were randomized to argon laser treatment (ALT) and 22 to diode laser treatment (DLT). The mean follow-up time was 25 ± 5 months in the ALT group versus 24 ± 4 montsh in the DLT group. In the ALT group 20 eyes (91 %) showed regression of PDR whereas 2 eyes (9%) deteriorated. In the DLT group regression of neovascularization was observed in 22 eyes (100%). These results show that the long-term efficacy of diode laser PRP in the treatment of PDR is similar to that of argon-green laser PRP.

UR - http://www.scopus.com/inward/record.url?scp=0027383835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027383835&partnerID=8YFLogxK

U2 - 10.1007/BF00921112

DO - 10.1007/BF00921112

M3 - Article

VL - 231

SP - 491

EP - 494

JO - Graefe's Archive for Clinical and Experimental Ophthalmology

JF - Graefe's Archive for Clinical and Experimental Ophthalmology

SN - 0721-832X

IS - 9

ER -